» Articles » PMID: 32253113

COVID-19: Yet Another Coronavirus Challenge in Transplantation

Overview
Authors
Affiliations
Soon will be listed here.
Citing Articles

Risk Factor Analysis of Death due to COVID-19 with Comorbid Condition in the Community of the Wetland Environment in Banjar District.

Kaidah S, Aflanie I, Rahman F, Yolanda Z, Fatimah H, Ridwan A Acta Med Philipp. 2024; 58(15):74-80.

PMID: 39308881 PMC: 11413458. DOI: 10.47895/amp.vi0.6409.


Outcome of COVID-19 in Egyptian living-donor kidney transplant recipients and relation to maintenance immunosuppressive drugs: a pilot study.

ElNahid M, Issac M, Marzouk Sadek K Sci Rep. 2023; 13(1):19002.

PMID: 37923735 PMC: 10624883. DOI: 10.1038/s41598-023-45750-8.


The psychological stress response of COVID-19 to medical staff and prevention: A large sample study from China.

Hu M, Xu Y, Bu D, Luo K, Chang L, Mao C Front Psychol. 2023; 14:1125847.

PMID: 37034918 PMC: 10074311. DOI: 10.3389/fpsyg.2023.1125847.


COVID-19 and Blood Clots: A Report of Massive Pulmonary Embolism in COVID-19 Patient Supported on Veno-Venous ECMO and the Utility of Thrombolysis.

Akkanti B, Zwischenberger J, Warner M, Dinh K, Hussain R, Kazzaz F J Extra Corpor Technol. 2023; 54(3):235-238.

PMID: 36742217 PMC: 9891489. DOI: 10.1182/ject-235-238.


How the Heart Was Involved in COVID-19 during the First Pandemic Phase: A Review.

Canalella A, Vitale E, Vella F, Senia P, Cannizzaro E, Ledda C Epidemiologia (Basel). 2022; 2(1):124-139.

PMID: 36417195 PMC: 9620895. DOI: 10.3390/epidemiologia2010011.


References
1.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

2.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

3.
Dong L, Hu S, Gao J . Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020; 14(1):58-60. DOI: 10.5582/ddt.2020.01012. View

4.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

5.
Mair-Jenkins J, Saavedra-Campos M, Baillie J, Cleary P, Khaw F, Lim W . The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2014; 211(1):80-90. PMC: 4264590. DOI: 10.1093/infdis/jiu396. View